Diane M Da Silva

10PUBLICATIONS
83CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsInnate immunityAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 30, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.

Eileen M O'Reilly, Christopher R Cabanski, Jaclyn P Lyman

|Aug 19, 2025
HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophages.

Ruben Prins, Daniel J Fernandez, Omid Akbari

|Feb 18, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer.

Matthew D Galsky, Karen A Autio, Christopher R Cabanski

|Aug 27, 2024
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.

Apostolia M Tsimberidou, Farah A Alayli, Kwame Okrah

|Jul 09, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma.

Jacob E Till, Lee McDaniel, Changgee Chang

|Jun 28, 2023
Diversity of Anal HPV and Non-HPV Sexually Transmitted Infections and Concordance with Genital Infections in HIV-Infected and HIV-Uninfected Women in the Tapajós Region, Amazon, Brazil.

Luana Lorena Silva Rodrigues, José Henrique Pilotto, Katrini Guidolini Martinelli

Pageof 2

Frequent Collaborators

4 joint publications

Christopher R Cabanski

4 joint publications

W Martin Kast

3 joint publications

Richard O Chen

2 joint publications

Justin Fairchild